ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,493Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 1692

$931K Total Retail Price of All Prescriptions

Rank: 47 out of 1692

704 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 704 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 704 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,492 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 523 378 1 1
WARFARIN SODIUM 485 443 2 14
OMEPRAZOLE 456 325 3 5
AMLODIPINE BESYLATE 454 398 4 3
LISINOPRIL 390 322 5 2
LEVOTHYROXINE SODIUM 375 317 6 4
METFORMIN HCL 368 239 7 8
ATORVASTATIN CALCIUM 308 219 8 11
FUROSEMIDE 280 212 9 7
TRAMADOL HCL 262 201 10 16
METOPROLOL SUCCINATE 251 218 11 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 223 164 12 19
METOPROLOL TARTRATE 212 189 13 10
HYDROCHLOROTHIAZIDE 210 151 14 9
CRESTOR 200 157 15 26
LOSARTAN POTASSIUM 193 150 16 17
CARVEDILOL 178 142 17 24
HYDROCODONE-ACETAMINOPHEN 163 140 S3 18 6
CITALOPRAM HBR 161 121 19 21
PRAVASTATIN SODIUM 154 148 20 12
GABAPENTIN 154 128 20 13
ADVAIR DISKUS 132 83 22 45
NEXIUM 117 99 23 25
OXYCODONE-ACETAMINOPHEN 115 79 S2 24 70
LANTUS 113 61 25 57
PREDNISONE 107 93 26 35
FLUTICASONE PROPIONATE 105 54 27 27
LOSARTAN-HYDROCHLOROTHIAZIDE 104 74 28 38
ZOLPIDEM TARTRATE 99 81 29 23
SPIRIVA 90 70 30 44
FENTANYL 87 59 S2 31 88
QUETIAPINE FUMARATE 85 72 32 62
NAMENDA 85 85 32 50
ESCITALOPRAM OXALATE 83 55 34 76
TAMSULOSIN HCL 82 44 35 31
FENOFIBRATE 82 63 35 63
ROPINIROLE HCL 80 63 37 101
BENAZEPRIL HCL 78 77 38 69
ALENDRONATE SODIUM 77 77 39 36
DIOVAN 76 76 40 42
AMLODIPINE BESYLATE-BENAZEPRIL 75 52 41 67
DONEPEZIL HCL 75 75 41 29
METFORMIN HCL ER 74 63 43 49
LYRICA 72 45 44 111
CLOPIDOGREL 66 44 45 43
OXYCODONE HCL 66 29 S2 45 56
JANUVIA 64 40 47 72
CYMBALTA 63 48 48 51
GLIMEPIRIDE 62 51 49 32
SERTRALINE HCL 62 52 49 22
COMBIVENT 61 43 51 141
ISOSORBIDE MONONITRATE ER 60 60 52 55
ONGLYZA 60 54 52 213
TRAZODONE HCL 58 32 54 33
OXYCODONE HCL-ACETAMINOPHEN 58 18 S2 54 94
LOVASTATIN 57 51 56 37
ALLOPURINOL 57 37 56 30
LANSOPRAZOLE 56 43 58 133
PROAIR HFA 56 36 58 40
MIRTAZAPINE 55 55 60 53
DIOVAN HCT 50 47 61 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.